Sumitomo Chemical India Ltd. (IN:SUMICHEM)
:SUMICHEM
Want to see IN:SUMICHEM full AI Analyst Report?
Top Page
Sumitomo Chemical India Ltd.
(SUMICHEM)
Select Model
Select Model
Rating:72Outperform
Price Target:
₹550.00
▲(17.36% Upside)
Action:Upgraded
Date:05/28/26
The score is driven primarily by strong underlying financial quality—solid margins and very low leverage—supported by favorable price momentum. These positives are tempered by a demanding valuation (high P/E and minimal yield) and some volatility in revenue and operating cash-flow conversion.
Positive Factors
Conservative balance sheet
Extremely low leverage (debt-to-equity ~1–2%) provides durable financial resilience through agricultural cycles, reduces insolvency risk, and preserves capacity to fund operations. This safety enables consistent investment in registrations and distributor relationships without pressuring cash flow during downturns.
Negative Factors
Revenue cyclicality
Revenue volatility and periodic down years reflect sensitivity to monsoon, crop cycles and pest incidence. This structural cyclicality complicates capacity planning, creates inconsistent top-line growth over multi-year horizons, and raises execution risk for steady expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage (debt-to-equity ~1–2%) provides durable financial resilience through agricultural cycles, reduces insolvency risk, and preserves capacity to fund operations. This safety enables consistent investment in registrations and distributor relationships without pressuring cash flow during downturns.
Read all positive factors
Sumitomo Chemical India Ltd. (SUMICHEM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹250.52B
Dividend Yield0.26%
Average Volume (3M)14.60K
Price to Earnings (P/E)46.1
Beta (1Y)1.11
Revenue Growth2.85%
EPS Growth7.43%
CountryIN
Employees1,649
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)10.87
Shares Outstanding499,145,720
10 Day Avg. Volume20,149
30 Day Avg. Volume14,601
Financial Highlights & Ratios
PEG Ratio4.52
Price to Book (P/B)5.37
Price to Sales (P/S)5.62
P/FCF Ratio38.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹515.00Price Target Upside9.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)12.84
Revenue Forecast (FY)₹36.18B
Sumitomo Chemical India Ltd. Business Overview & Revenue Model
Company Description
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It operates through two segments, Agro Chemicals ...
How the Company Makes Money
SUMICHEM primarily makes money by selling agricultural input products, with revenue largely driven by (1) branded and/or formulated crop protection products sold into India through distributors, retailers, and institutional channels, and (2) expor...
Sumitomo Chemical India Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
67
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.08B | 32.38B | 31.49B | 28.44B | 35.11B | 30.61B |
| Gross Profit | 12.40B | 10.21B | 12.70B | 10.49B | 12.24B | 11.36B |
| EBITDA | 6.83B | 6.71B | 6.10B | 4.53B | 6.47B | 5.82B |
| Net Income | 5.43B | 5.43B | 5.05B | 3.70B | 5.02B | 4.24B |
Balance Sheet | ||||||
| Total Assets | 44.39B | 44.74B | 39.64B | 33.13B | 33.69B | 30.10B |
| Cash, Cash Equivalents and Short-Term Investments | 11.33B | 10.08B | 12.59B | 8.91B | 5.63B | 5.75B |
| Total Debt | 582.48M | 633.00M | 518.93M | 302.49M | 339.72M | 375.84M |
| Total Liabilities | 12.37B | 10.80B | 10.59B | 8.69B | 9.87B | 10.82B |
| Stockholders Equity | 31.97B | 33.90B | 29.01B | 24.42B | 23.82B | 19.27B |
Cash Flow | ||||||
| Free Cash Flow | 4.20B | 4.78B | 4.87B | 6.93B | 2.70B | 1.08B |
| Operating Cash Flow | 4.35B | 5.22B | 5.17B | 7.57B | 3.89B | 2.22B |
| Investing Cash Flow | -3.60B | -4.08B | -4.57B | -4.20B | -3.27B | -2.90B |
| Financing Cash Flow | -726.93M | -828.79M | -679.20M | -3.37B | -725.45M | -626.38M |
Sumitomo Chemical India Ltd. Technical Analysis
Positive
468.65
Price Trends
432.39
Positive
426.85
Positive
473.76
Positive
Market Momentum
14.88
Negative
65.55
Neutral
89.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUMICHEM, the sentiment is Positive. The current price of 468.65 is below the 20-day moving average (MA) of 469.46, above the 50-day MA of 432.39, and below the 200-day MA of 473.76, indicating a bullish trend. The MACD of 14.88 indicates Negative momentum. The RSI at 65.55 is Neutral, neither overbought nor oversold. The STOCH value of 89.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SUMICHEM.
Sumitomo Chemical India Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹81.80B | 11.99 | ― | 1.02% | 21.94% | 123.70% | |
72 Outperform | ₹250.52B | 46.07 | ― | 0.26% | 2.85% | 7.43% | |
68 Neutral | ₹203.00B | 29.40 | ― | 1.57% | 3.71% | 21.34% | |
64 Neutral | ₹47.36B | 25.09 | ― | 0.92% | 8.79% | 47.20% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹545.97B | 28.32 | ― | 0.77% | 11.15% | 127.12% | |
55 Neutral | ₹422.63B | 31.87 | ― | 0.49% | -15.85% | -20.44% |
* Basic Materials Sector Average
IN:SUMICHEM
Sumitomo Chemical India Ltd.
501.90
-2.22
-0.44%
IN:BAYERCROP
Bayer Cropscience India Limited
4,516.85
-953.65
-17.43%
IN:PIIND
PI Industries Limited
2,785.60
-1,026.61
-26.93%
IN:RALLIS
Rallis India Limited
243.55
-68.75
-22.01%
IN:SHARDACROP
Sharda Cropchem Ltd.
906.65
190.43
26.59%
IN:UPL
UPL Limited
646.75
16.32
2.59%
Sumitomo Chemical India Ltd. Corporate Events
Sumitomo Chemical India Shares FY26 Results in Investor Presentation
May 27, 2026
Sumitomo Chemical India Ltd. has released an investor presentation detailing its financial results for the quarter and full year ended 31 March 2026. The company has submitted this presentation to both BSE and NSE for disclosure under securities r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.